Leptin/adiponectin ratio predicts poststroke neurological outcome

Federico Carbone, Fabienne Burger, Gloria Roversi, Carmine Tamborino, Ilaria Casetta, Silva Seraceni, Alessandro Trentini, Marina Padroni, Maria Bertolotto, Franco Dallegri, François Mach, Enrico Fainardi, Fabrizio Montecucco

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Background and aims: Different adipokines have been associated with atherosclerotic plaque rupture and cardiovascular events, such as acute ischaemic stroke (AIS). However, the potential role of these molecules in postischaemic brain injury remains largely unknown. Methods and methods: We performed a substudy analysis on nonobese patients with first atherothrombotic stroke (n = 35) from a recently published prospective cohort. Primary endpoint was to investigate the predictive value of serum leptin/adiponectin ratio on neurological recovery at 90 days after AIS. The secondary endpoint was the predictive value of serum adipokine levels of clinical and radiological outcomes at a shorter follow-up (at days 1 and 7 after AIS). The radiological evaluation included ischaemic lesion volume and haemorrhagic transformation (HT). The clinical examination was based on National Institutes of Health Stroke Scale (NIHSS) and modified Rankin Scale (mRS). Results: At day 1 after AIS, serum leptin and leptin/adiponectin ratio were increased and inversely correlated with both radiological and clinical parameters at all follow-up time points. Once identified the best cut-off points by receiver operating characteristic (ROC) analysis, risk analysis showed that higher circulating leptin improved neurological recovery at day 90. In addition, leptin/adiponectin ratio maintained statistical significance after adjustment for age, gender and thrombolysis, also predicting the occurrence of HT in the first 7 days after AIS (adjusted OR 0·15 [95% CI 0·03-0·83); P = 0·030]). Conclusions: Higher leptin/adiponectin ratio at day 1 predicted better neurological outcomes in patients with atherothrombotic AIS and might be potentially useful as a prognostic biomarker of the disease.

Original languageEnglish
Pages (from-to)1184-1191
Number of pages8
JournalEuropean Journal of Clinical Investigation
Volume45
Issue number11
DOIs
Publication statusPublished - Nov 1 2015

Fingerprint

Adiponectin
Leptin
Stroke
Adipokines
Recovery
Serum
Biomarkers
Risk analysis
Brain
National Institutes of Health (U.S.)
Atherosclerotic Plaques
Health
ROC Curve
Brain Injuries
Rupture
Molecules

Keywords

  • Acute ischaemic stroke
  • Adipokines
  • Adiponectin
  • Computed tomography
  • Leptin
  • Resistin

ASJC Scopus subject areas

  • Medicine(all)
  • Clinical Biochemistry
  • Biochemistry

Cite this

Carbone, F., Burger, F., Roversi, G., Tamborino, C., Casetta, I., Seraceni, S., ... Montecucco, F. (2015). Leptin/adiponectin ratio predicts poststroke neurological outcome. European Journal of Clinical Investigation, 45(11), 1184-1191. https://doi.org/10.1111/eci.12538

Leptin/adiponectin ratio predicts poststroke neurological outcome. / Carbone, Federico; Burger, Fabienne; Roversi, Gloria; Tamborino, Carmine; Casetta, Ilaria; Seraceni, Silva; Trentini, Alessandro; Padroni, Marina; Bertolotto, Maria; Dallegri, Franco; Mach, François; Fainardi, Enrico; Montecucco, Fabrizio.

In: European Journal of Clinical Investigation, Vol. 45, No. 11, 01.11.2015, p. 1184-1191.

Research output: Contribution to journalArticle

Carbone, F, Burger, F, Roversi, G, Tamborino, C, Casetta, I, Seraceni, S, Trentini, A, Padroni, M, Bertolotto, M, Dallegri, F, Mach, F, Fainardi, E & Montecucco, F 2015, 'Leptin/adiponectin ratio predicts poststroke neurological outcome', European Journal of Clinical Investigation, vol. 45, no. 11, pp. 1184-1191. https://doi.org/10.1111/eci.12538
Carbone F, Burger F, Roversi G, Tamborino C, Casetta I, Seraceni S et al. Leptin/adiponectin ratio predicts poststroke neurological outcome. European Journal of Clinical Investigation. 2015 Nov 1;45(11):1184-1191. https://doi.org/10.1111/eci.12538
Carbone, Federico ; Burger, Fabienne ; Roversi, Gloria ; Tamborino, Carmine ; Casetta, Ilaria ; Seraceni, Silva ; Trentini, Alessandro ; Padroni, Marina ; Bertolotto, Maria ; Dallegri, Franco ; Mach, François ; Fainardi, Enrico ; Montecucco, Fabrizio. / Leptin/adiponectin ratio predicts poststroke neurological outcome. In: European Journal of Clinical Investigation. 2015 ; Vol. 45, No. 11. pp. 1184-1191.
@article{4e1317eaa04640df86863a6119f19b01,
title = "Leptin/adiponectin ratio predicts poststroke neurological outcome",
abstract = "Background and aims: Different adipokines have been associated with atherosclerotic plaque rupture and cardiovascular events, such as acute ischaemic stroke (AIS). However, the potential role of these molecules in postischaemic brain injury remains largely unknown. Methods and methods: We performed a substudy analysis on nonobese patients with first atherothrombotic stroke (n = 35) from a recently published prospective cohort. Primary endpoint was to investigate the predictive value of serum leptin/adiponectin ratio on neurological recovery at 90 days after AIS. The secondary endpoint was the predictive value of serum adipokine levels of clinical and radiological outcomes at a shorter follow-up (at days 1 and 7 after AIS). The radiological evaluation included ischaemic lesion volume and haemorrhagic transformation (HT). The clinical examination was based on National Institutes of Health Stroke Scale (NIHSS) and modified Rankin Scale (mRS). Results: At day 1 after AIS, serum leptin and leptin/adiponectin ratio were increased and inversely correlated with both radiological and clinical parameters at all follow-up time points. Once identified the best cut-off points by receiver operating characteristic (ROC) analysis, risk analysis showed that higher circulating leptin improved neurological recovery at day 90. In addition, leptin/adiponectin ratio maintained statistical significance after adjustment for age, gender and thrombolysis, also predicting the occurrence of HT in the first 7 days after AIS (adjusted OR 0·15 [95{\%} CI 0·03-0·83); P = 0·030]). Conclusions: Higher leptin/adiponectin ratio at day 1 predicted better neurological outcomes in patients with atherothrombotic AIS and might be potentially useful as a prognostic biomarker of the disease.",
keywords = "Acute ischaemic stroke, Adipokines, Adiponectin, Computed tomography, Leptin, Resistin",
author = "Federico Carbone and Fabienne Burger and Gloria Roversi and Carmine Tamborino and Ilaria Casetta and Silva Seraceni and Alessandro Trentini and Marina Padroni and Maria Bertolotto and Franco Dallegri and Fran{\cc}ois Mach and Enrico Fainardi and Fabrizio Montecucco",
year = "2015",
month = "11",
day = "1",
doi = "10.1111/eci.12538",
language = "English",
volume = "45",
pages = "1184--1191",
journal = "European Journal of Clinical Investigation",
issn = "0014-2972",
publisher = "Blackwell Publishing Ltd",
number = "11",

}

TY - JOUR

T1 - Leptin/adiponectin ratio predicts poststroke neurological outcome

AU - Carbone, Federico

AU - Burger, Fabienne

AU - Roversi, Gloria

AU - Tamborino, Carmine

AU - Casetta, Ilaria

AU - Seraceni, Silva

AU - Trentini, Alessandro

AU - Padroni, Marina

AU - Bertolotto, Maria

AU - Dallegri, Franco

AU - Mach, François

AU - Fainardi, Enrico

AU - Montecucco, Fabrizio

PY - 2015/11/1

Y1 - 2015/11/1

N2 - Background and aims: Different adipokines have been associated with atherosclerotic plaque rupture and cardiovascular events, such as acute ischaemic stroke (AIS). However, the potential role of these molecules in postischaemic brain injury remains largely unknown. Methods and methods: We performed a substudy analysis on nonobese patients with first atherothrombotic stroke (n = 35) from a recently published prospective cohort. Primary endpoint was to investigate the predictive value of serum leptin/adiponectin ratio on neurological recovery at 90 days after AIS. The secondary endpoint was the predictive value of serum adipokine levels of clinical and radiological outcomes at a shorter follow-up (at days 1 and 7 after AIS). The radiological evaluation included ischaemic lesion volume and haemorrhagic transformation (HT). The clinical examination was based on National Institutes of Health Stroke Scale (NIHSS) and modified Rankin Scale (mRS). Results: At day 1 after AIS, serum leptin and leptin/adiponectin ratio were increased and inversely correlated with both radiological and clinical parameters at all follow-up time points. Once identified the best cut-off points by receiver operating characteristic (ROC) analysis, risk analysis showed that higher circulating leptin improved neurological recovery at day 90. In addition, leptin/adiponectin ratio maintained statistical significance after adjustment for age, gender and thrombolysis, also predicting the occurrence of HT in the first 7 days after AIS (adjusted OR 0·15 [95% CI 0·03-0·83); P = 0·030]). Conclusions: Higher leptin/adiponectin ratio at day 1 predicted better neurological outcomes in patients with atherothrombotic AIS and might be potentially useful as a prognostic biomarker of the disease.

AB - Background and aims: Different adipokines have been associated with atherosclerotic plaque rupture and cardiovascular events, such as acute ischaemic stroke (AIS). However, the potential role of these molecules in postischaemic brain injury remains largely unknown. Methods and methods: We performed a substudy analysis on nonobese patients with first atherothrombotic stroke (n = 35) from a recently published prospective cohort. Primary endpoint was to investigate the predictive value of serum leptin/adiponectin ratio on neurological recovery at 90 days after AIS. The secondary endpoint was the predictive value of serum adipokine levels of clinical and radiological outcomes at a shorter follow-up (at days 1 and 7 after AIS). The radiological evaluation included ischaemic lesion volume and haemorrhagic transformation (HT). The clinical examination was based on National Institutes of Health Stroke Scale (NIHSS) and modified Rankin Scale (mRS). Results: At day 1 after AIS, serum leptin and leptin/adiponectin ratio were increased and inversely correlated with both radiological and clinical parameters at all follow-up time points. Once identified the best cut-off points by receiver operating characteristic (ROC) analysis, risk analysis showed that higher circulating leptin improved neurological recovery at day 90. In addition, leptin/adiponectin ratio maintained statistical significance after adjustment for age, gender and thrombolysis, also predicting the occurrence of HT in the first 7 days after AIS (adjusted OR 0·15 [95% CI 0·03-0·83); P = 0·030]). Conclusions: Higher leptin/adiponectin ratio at day 1 predicted better neurological outcomes in patients with atherothrombotic AIS and might be potentially useful as a prognostic biomarker of the disease.

KW - Acute ischaemic stroke

KW - Adipokines

KW - Adiponectin

KW - Computed tomography

KW - Leptin

KW - Resistin

UR - http://www.scopus.com/inward/record.url?scp=84944698646&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84944698646&partnerID=8YFLogxK

U2 - 10.1111/eci.12538

DO - 10.1111/eci.12538

M3 - Article

C2 - 26381386

AN - SCOPUS:84944698646

VL - 45

SP - 1184

EP - 1191

JO - European Journal of Clinical Investigation

JF - European Journal of Clinical Investigation

SN - 0014-2972

IS - 11

ER -